Diabetic ketoacidosis is a common severe complication of diabetes, which develops when the body can't produce enough insulin. During DKA the body starts breaking down fat, causing a buildup of acids ...
To develop DKA, the patient must experience a relative insulin deficiency 4 (very little circulating insulin) in the setting of increased counter-regulatory hormone concentrations. This relative lack ...
A subcutaneous insulin-driven treatment protocol for diabetic ketoacidosis (DKA), instead of continuous intravenous insulin, can reduce intensive care unit (ICU) admission and hospital readmission in ...
At the beginning of every year, I try to consider what I can do better when it comes to managing my patients with diabetes. This year, I've decided I need to be better at prescribing both glucagon and ...
Considerable research on diabetic ketoacidosis (DKA) risk has been published since the publication of a 2011 systematic review, warranting an updated analysis. Being younger than 2 years at type 1 ...
New ADA 2026 data show diabetic ketoacidosis hospitalizations rising 24%, driven by poor ketone monitoring and symptom recognition gaps across all ages. A key driver of that burden is recognition—or ...
Diabetic ketoacidosis (DKA) is a complication of diabetes. It can occur when the body does not have enough insulin to use sugar as energy. Instead, it breaks down fat and produces ketones. This can ...
A 26-year-old with Type 1 diabetes died after replacing insulin with diabetes pills. Doctors explain why insulin is ...
The first mealtime after the acidosis has resolved and the patient feels that he or she can tolerate food is the time to begin feeding the patient. Subcutaneous insulin should be started ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results